LOS ANGELES
,
June 20, 2022
(Industry Intelligence Inc.)
–
UK-based Modern Synthesis, a biomaterials manufacturer, has raised US$4.1M to fund its bacterial ‘bioweaving’ technology, which produces nanocellulose fibers from textile waste, AgFunderNews reported June 1. The company’s genetically modified bacteria feed on sugars from textile waste. The sugar is converted into nanocellulose, which the bacteria deposit onto robotically engineered scaffolds designed by the company’s technicians. According to the company, it has already prototyped the upper portion of a shoe using their bioweaving process. The process takes roughly two weeks to complete. Modern Synthesis plans to use the majority of its seed funding to establish a pilot manufacturing laboratory in London, which should be operating by Q3. The primary source for this article is AgFunderNews, California, published on June 1, 2022. To read the original article, click here.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
